Results 1 to 10 of about 75,264 (232)
Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms. [PDF]
Adv Anat Pathol, 2018 The diagnosis of a neurofibroma or a malignant peripheral nerve sheath tumor (MPNST) often raises the question of whether the patient has the genetic disorder neurofibromatosis type 1 (NF1) as well as how this will impact the patient’s outcome, what their risk is for developing additional neoplasms and whether treatment options differ for NF1 ...
Longo JF +3 more
europepmc +3 more sources
Large schwannoma of the median nerve at the distal forearm [PDF]
Vojnosanitetski Pregled, 2023 Introduction. Schwannoma, also known as neurilemmoma, is a rare but one of the most common tumors of the peripheral nerves. It originates from Schwann cells of the peripheral nerve sheaths. Schwannoma mostly occurs in adults between 20 to 70 years of age.
Vulović Dejan +8 more
doaj +1 more source
Immunohistochemical Study of Ki-67 Labelling Index in Neoplasms of Central Nervous System [PDF]
National Journal of Laboratory Medicine, 2022 Introduction: The central nervous system tumours show a varied histopathological spectrum. The cell proliferation index may provide an objective method for assessing tumour biology. The Ki-67 is considered to be the most reliable proliferative marker
Anuradha G Patil +3 more
doaj +1 more source
BMC Musculoskeletal Disorders, 2023 Background Benign peripheral nerve tumours consist of different types, most commonly Schwannomas. Preoperative Magnetic Resonance Imaging (MRI) is commonly performed before surgery and Pathoanatomical Diagnosis (PAD) confirms the diagnosis. Our aims were
Emanuel Istefan +3 more
doaj +1 more source
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse. [PDF]
PLoS ONE, 2013 Bortezomib is the first proteasome inhibitor with significant antineoplastic activity for the treatment of relapsed/refractory multiple myeloma as well as other hematological and solid neoplasms.
Valentina A Carozzi +12 more
doaj +1 more source
South Asian Journal of Cancer, 2021 Background Many chemotherapeutic agents, especially taxanes, can induce peripheral neuropathy. Aim To evaluate the clinical characteristics of taxane-induced neuropathy (TIN) and determine the proper assessment tool for TIN in patients with ...
Eun Hee Sohn +3 more
doaj +1 more source
Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system [PDF]
Brain Research Bulletin, 2012 Neurofibromatosis type 1 (NF1), the most common genetic disorder affecting the human nervous system, is characterized by the development of multiple benign Schwann cell tumors in skin and large peripheral nerves. These neoplasms, which are termed dermal and plexiform neurofibromas respectively, have distinct clinical courses; of particular note ...
Nicole M, Brossier, Steven L, Carroll
openaire +2 more sources
Intravascular schwannoma as an extremely unusual cause of vein obstruction: a case report [PDF]
Journal of Pathology and Translational MedicineThe blood vessel lumen is an extremely rare location for a benign peripheral nerve sheath tumor like schwannoma. Less than 10 cases have been previously reported.
Luis Miguel Chinchilla-Tábora +9 more
doaj +1 more source
The Korean Journal of Gastroenterology, 2018 A primary benign schwannoma of the liver is extremely rare. Only 30 cases have been reported in the medical literature worldwide, and only one case has been reported in Korea previously.
Youn I Choi +9 more
doaj +1 more source
Peripheral nerve sheath malignancy with multiple metastasis: a rare clinical case
Кубанский научный медицинский вестник, 2021 Background. Tumours of peripheral nervous system are represented by benign and malignant neoplasms with different clinical and biological traits.
S. S. Todorov +3 more
doaj +1 more source